News

What's going on at LabCorp? (September 10, 2007)
See interview with Dr. Andrew Conrad, Chief Scientific Oficer of National Genetics Institute and Global Head of Esoterix Clinical Trials Services from Next Generation Pharmaceutical.

LabCorp Launches Enhanced HIV Screening Assay (November 7, 2005)
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the introduction of an enhanced HIV Screening Assay to identify individuals with primary HIV infection.